ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 192 filers reported holding ALKERMES PLC in Q1 2020. The put-call ratio across all filers is 3.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,552,825 | -10.1% | 305,349 | +0.4% | 0.00% | 0.0% |
Q2 2023 | $9,515,826 | +7.5% | 304,020 | -3.2% | 0.00% | 0.0% |
Q1 2023 | $8,851,068 | +10.9% | 313,979 | +2.8% | 0.00% | 0.0% |
Q4 2022 | $7,982,008 | +19.3% | 305,473 | +1.9% | 0.00% | 0.0% |
Q3 2022 | $6,691,000 | -26.9% | 299,644 | -2.5% | 0.00% | 0.0% |
Q2 2022 | $9,155,000 | +13.4% | 307,322 | +0.2% | 0.00% | +50.0% |
Q1 2022 | $8,072,000 | +13.4% | 306,786 | +0.3% | 0.00% | 0.0% |
Q4 2021 | $7,117,000 | -21.8% | 305,951 | +3.7% | 0.00% | -33.3% |
Q3 2021 | $9,099,000 | +43.0% | 295,037 | +13.7% | 0.00% | +50.0% |
Q2 2021 | $6,365,000 | +41.7% | 259,561 | +7.9% | 0.00% | 0.0% |
Q1 2021 | $4,492,000 | -4.3% | 240,461 | +2.2% | 0.00% | 0.0% |
Q4 2020 | $4,693,000 | +11.6% | 235,204 | -7.3% | 0.00% | 0.0% |
Q3 2020 | $4,204,000 | -17.3% | 253,742 | -3.1% | 0.00% | 0.0% |
Q2 2020 | $5,083,000 | +39.6% | 261,922 | +3.7% | 0.00% | 0.0% |
Q1 2020 | $3,640,000 | -31.3% | 252,457 | -2.7% | 0.00% | -33.3% |
Q4 2019 | $5,296,000 | -50.8% | 259,571 | -52.9% | 0.00% | -50.0% |
Q3 2019 | $10,756,000 | -48.2% | 551,295 | -40.1% | 0.01% | -45.5% |
Q2 2019 | $20,762,000 | -29.9% | 921,121 | +13.5% | 0.01% | -35.3% |
Q1 2019 | $29,625,000 | +57.2% | 811,866 | +27.1% | 0.02% | +13.3% |
Q4 2018 | $18,848,000 | -26.2% | 638,672 | +6.1% | 0.02% | -16.7% |
Q3 2018 | $25,545,000 | +2.6% | 601,912 | -0.4% | 0.02% | -5.3% |
Q2 2018 | $24,886,000 | -32.1% | 604,616 | -4.4% | 0.02% | -32.1% |
Q1 2018 | $36,652,000 | +3.1% | 632,357 | -2.7% | 0.03% | +7.7% |
Q4 2017 | $35,562,000 | +4.7% | 649,773 | -2.7% | 0.03% | 0.0% |
Q3 2017 | $33,962,000 | -10.5% | 668,021 | +2.0% | 0.03% | -16.1% |
Q2 2017 | $37,956,000 | +9.2% | 654,744 | +10.2% | 0.03% | +6.9% |
Q1 2017 | $34,756,000 | +12.1% | 594,120 | +6.5% | 0.03% | 0.0% |
Q4 2016 | $31,014,000 | – | 558,008 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |